Takashi Fukuoka

New Model of Oropharyngeal Candidiasis in Mice

Yasuki Kamai, Mikie Kubota, Yoko Kamai et al. · Antimicrobial Agents and Chemotherapy · 2001 · 113 citations · Full text

Dentistry, Infectious Diseases, Microbiology +16

Genetic Basis for Differential Activities of Fluconazole and Voriconazole against <i>Candida krusei</i>

Takashi Fukuoka, Douglas A. Johnston, Carol A. Winslow et al. · Antimicrobial Agents and Chemotherapy · 2003 · 95 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo

Tetsufumi Koga, Takashi Fukuoka, Norio Doi et al. · Journal of Antimicrobial Chemotherapy · 2004 · 86 citations · Full text

Medicine, Infectious Diseases, Medicinal Chemistry +15

Contribution of <i>Candida albicans ALS1</i> to the Pathogenesis of Experimental Oropharyngeal Candidiasis

Yasuki Kamai, Mikie Kubota, Tsunemichi Hosokawa et al. · Infection and Immunity · 2002 · 75 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

Hitoshi Hotoda, Miyuki Furukawa, Makiko Daigo et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12